SOUTH SAN FRANCISCO, Calif., Aug. 18, 2025 /PRNewswire/ — IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced agenda topics for its in-person R&D Day in conjunction with the company’s 10-Year Anniversary on September 8, 2025 in New York from 8:00-10:30am EST. Members of… Continue reading IDEAYA Biosciences Announces Agenda for 10-Year Anniversary R&D Day on September 8, 2025
Author: PR Newswire Online News
E-bike Market worth $87.2 billion by 2032| MarketsandMarkets™
DELRAY BEACH, Fla., Aug. 18, 2025 /PRNewswire/ — The E-Bike market is projected to grow from USD 54.1 billion in 2025 to USD 87.2 billion by 2032 at a CAGR of 7.0%, according to a new report by MarketsandMarkets. The global e-bike market is showing signs of recovery and steady growth following a period of fluctuation… Continue reading E-bike Market worth $87.2 billion by 2032| MarketsandMarkets™
Izalontamab Brengitecan (EGFRxHER3 ADC) Granted Breakthrough Therapy Designation by U.S. FDA for Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer
First Breakthrough Therapy Designation in the U.S. for SystImmune and Bristol Myers Squibb’s Izalontamab brengitecan (Iza-bren) based on data from the BL-B01D1-101 (CN), BL-B01D1-203 (CN), and BL-B01D1-LUNG-101 (U.S.,/EU) studies REDMOND, Wash. and PRINCETON, N.J., Aug. 18, 2025 /PRNewswire/ — SystImmune Inc. (SystImmune), a clinical-stage biotechnology company, and Bristol Myers Squibb (NYSE: BMY) today announced that the… Continue reading Izalontamab Brengitecan (EGFRxHER3 ADC) Granted Breakthrough Therapy Designation by U.S. FDA for Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer
India’s leading healthcare network Manipal Hospitals welcomes India’s leading cancer specialist Dr. Surender Kumar Dabas to strengthen robotic cancer care in Delhi NCR
NEW DELHI, Aug. 18, 2025 /PRNewswire/ — Manipal Hospitals, one of India’s leading and globally recognized healthcare institutions, welcomes one of India’s most renowned robotic oncosurgeons, Dr. Surender Kumar Dabas as Chairman – Manipal Comprehensive Cancer Centre and Onco Robotic Surgeries, North-West Cluster. With this addition, the hospital across Delhi, Gurugram and Ghaziabad further reinforces its vision… Continue reading India’s leading healthcare network Manipal Hospitals welcomes India’s leading cancer specialist Dr. Surender Kumar Dabas to strengthen robotic cancer care in Delhi NCR
TCL SunPower Global et Energia Italia annoncent un partenariat stratégique de distribution
Avec cette nouvelle collaboration avec un spécialiste reconnu dans le secteur de l’énergie résidentiel et tertiaire, TCL SunPower Global démocratise la technologie photovoltaïque de haute performante sur le marché italien. MILAN et CAMPOBELLO DI MAZARA, Italie, 18 août 2025 /PRNewswire/ — TCL SunPower Global, leader de solutions solaires innovantes, annonce un partenariat stratégique avec Energia… Continue reading TCL SunPower Global et Energia Italia annoncent un partenariat stratégique de distribution
VVDN Acquires GGS Engineering, Expanding its ER&D Portfolio in Automotive, MedTech and Aerospace Industries
GURUGRAM, India, Aug. 18, 2025 /PRNewswire/ — VVDN Technologies, a global provider of software, product engineering and electronics manufacturing services & solutions, today announced the acquisition of GGS Engineering Services, a leading engineering solutions company specializing in offering enhanced ER&D services for the Automotive, MedTech and Aerospace industries. With this acquisition, VVDN has onboarded engineers… Continue reading VVDN Acquires GGS Engineering, Expanding its ER&D Portfolio in Automotive, MedTech and Aerospace Industries
Polylactic Acid Market worth $4.51 billion by 2030 – Exclusive Report by MarketsandMarkets™
DELRAY BEACH, Fla., Aug. 18, 2025 /PRNewswire/ — The report “Polylactic Acid Market by Grade (Thermoforming Grade, Injection Molding Grade, Extrusion Grade, Blow Molding Grade), Application (Rigid Thermoforms, Films & Sheets, Bottles), End-use Industry (Packaging, Consumer Goods, Agricultural, Textile, Bio-Medical), Raw Material (Sugarcane, Corn starch, Cassava, Sugarbeet), and Region – Global Forecast to 2030 “, polylactic… Continue reading Polylactic Acid Market worth $4.51 billion by 2030 – Exclusive Report by MarketsandMarkets™
DouYu International Holdings Limited Reports Second Quarter 2025 Unaudited Financial Results
WUHAN, China, Aug. 18, 2025 /PRNewswire/ — DouYu International Holdings Limited (“DouYu” or the “Company”) (Nasdaq: DOYU), a leading game-centric live streaming platform in China and a pioneer in the eSports value chain, today announced its unaudited financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Financial Highlights Total net revenues in the second quarter of 2025 were RMB1,053.9 million… Continue reading DouYu International Holdings Limited Reports Second Quarter 2025 Unaudited Financial Results
RxSight, Inc. Investigated for Securities Fraud Violations – Contact the DJS Law Group to Discuss Your Rights – RXST
LOS ANGELES, Aug. 18, 2025 /PRNewswire/ — The DJS Law Group announces that it is investigating claims on behalf of investors of RxSight, Inc. (“RxSight” or “the Company”) (NASDAQ: RXST) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements and/or failed to disclose information pertinent to investors. RxSight… Continue reading RxSight, Inc. Investigated for Securities Fraud Violations – Contact the DJS Law Group to Discuss Your Rights – RXST
SPPI Investors Have Opportunity to Lead Spectrum Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, Aug. 18, 2025 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Spectrum Pharmaceuticals, Inc. (“Spectrum” or “the Company”) (NASDAQ: SPPI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange… Continue reading SPPI Investors Have Opportunity to Lead Spectrum Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm